{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05547880",
            "orgStudyIdInfo": {
                "id": "2804"
            },
            "secondaryIdInfos": [
                {
                    "id": "MO220146",
                    "type": "OTHER_GRANT",
                    "domain": "Military Operational Medicine Research Program"
                }
            ],
            "organization": {
                "fullName": "Walter Reed Army Institute of Research (WRAIR)",
                "class": "FED"
            },
            "briefTitle": "CNS Correlates of Extended Sleep Restriction",
            "officialTitle": "CNS Correlates of Extended Sleep Restriction",
            "therapeuticArea": [
                "Other"
            ],
            "study": "cns-correlates-of-extended-sleep-restriction"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-08",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-05-23",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-09-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-07-26",
            "studyFirstSubmitQcDate": "2022-09-15",
            "studyFirstPostDateStruct": {
                "date": "2022-09-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-08-12",
            "lastUpdatePostDateStruct": {
                "date": "2023-08-15",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Samantha Riedy",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Walter Reed Army Institute of Research (WRAIR)"
            },
            "leadSponsor": {
                "name": "Walter Reed Army Institute of Research (WRAIR)",
                "class": "FED"
            },
            "collaborators": [
                {
                    "name": "National Institute of Mental Health (NIMH)",
                    "class": "NIH"
                },
                {
                    "name": "National Intrepid Center of Excellence",
                    "class": "FED"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Chronic sleep restriction is ubiquitous in both the general population and the military. The deleterious effects of sleep loss on human alertness and cognitive performance have been documented in numerous studies dating back to the nineteenth century. Over the past decade, evidence has emerged indicating that chronic sleep restriction may also precipitate deleterious, long lasting neuropathological changes in the brain. The purpose of this study is to determine neuropathological effects of sleep restriction and identify physiological mechanisms that correlate with sleep loss-induced performance impairment."
        },
        "conditionsModule": {
            "conditions": [
                "Sleep Restriction"
            ],
            "keywords": [
                "Sleep Restriction",
                "Alertness",
                "Performance",
                "Neuroinflammation",
                "Biomarker"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITH_DNA",
                "description": "Whole blood, plasma"
            },
            "enrollmentInfo": {
                "count": 18,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "[11C]ER176",
                    "description": "Brain PET with \\[11C\\]ER176. \\[11C\\]ER176 is a PET ligand that images TSPO."
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Positron Emission Tomography (PET) based measurement of neuroinflammation",
                    "description": "Positron Emission Tomography (PET) is the brain imaging method and \\[11C\\]ER176 is the PET radioligand providing an index of neuroinflammation",
                    "timeFrame": "3 Days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Psychomotor Vigilance Task (PVT)",
                    "description": "Measure of cognitive performance",
                    "timeFrame": "55 Days"
                },
                {
                    "measure": "Actigraphy",
                    "description": "Activity monitoring used to infer sleep-wake patterns",
                    "timeFrame": "55 Days"
                },
                {
                    "measure": "Polysomnographic measurements of sleep and wakefulness",
                    "description": "Measure of various aspects of sleep and wakefulness",
                    "timeFrame": "19 Days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "* Ages 18 to 39 (inclusive)\n* Weigh at least 140 lbs\n* A body mass index (BMI) below 30.\n* Females must not be pregnant or nursing, and must be on some form of birth control, if sexually active (e.g., oral contraceptive, condom, intrauterine device, etc.)\n* No history of sleeping problems such as insomnia or sleep apnea.\n* Test negative for alcohol, nicotine, illegal drugs, and not take certain medications.\n* Must not excessively consume alcohol or caffeine.\n* Active duty and Federal employees must be on leave during participation.\n* No history of heart disease (high blood pressure), neurologic disorder (such as seizures of epilepsy), liver disease, kidney disease, or metabolic disorder or diabetes.\n* No history of underlying acute or chronic pulmonary disease requiring daily inhaler use.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "39 Years",
            "stdAges": [
                "ADULT"
            ],
            "studyPopulation": "Community sample",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Samantha M Riedy, PhD",
                    "role": "CONTACT",
                    "phone": "301-319-3944",
                    "email": "samantha.m.riedy.ctr@health.mil"
                },
                {
                    "name": "Vincent F Capaldi, MD",
                    "role": "CONTACT",
                    "phone": "301-319-9098",
                    "email": "vincent.f.capaldi.mil@health.mil"
                }
            ],
            "locations": [
                {
                    "facility": "Walter Reed Army Institute of Research",
                    "status": "RECRUITING",
                    "city": "Silver Spring",
                    "state": "Maryland",
                    "zip": "20910",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Samantha Riedy, PhD",
                            "role": "CONTACT",
                            "phone": "301-337-1323",
                            "email": "samantha.m.riedy.ctr@health.mil"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.99067,
                        "lon": -77.02609
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "12603781",
                    "type": "BACKGROUND",
                    "citation": "Belenky G, Wesensten NJ, Thorne DR, Thomas ML, Sing HC, Redmond DP, Russo MB, Balkin TJ. Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: a sleep dose-response study. J Sleep Res. 2003 Mar;12(1):1-12. doi: 10.1046/j.1365-2869.2003.00337.x."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        }
    },
    "hasResults": false
}